Publikationen von C. Griesinger
Alle Typen
Meeting Abstract (7)
341.
Meeting Abstract
279 (Suppl. 1), P20-86, S. 433 - 433. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, 04. September 2012 - 09. September 2012. (2012)
Functional dynamics in the voltage-dependent anion channel. In FEBS Journal, 342.
Meeting Abstract
21 (Supplement 1), S. 96 - 96. 26th Annual Symposium of the Protein-Society, San Diego, CA, 05. August 2012 - 08. August 2012. (2012)
Exceeding the limit of dynamics studies on proteins using NMR spectroscopy. In Protein Science, 343.
Meeting Abstract
21 (Supplement 1), S. 146 - 146. 26th Annual Symposium of the Protein-Society, San Diego, CA, 05. August 2012 - 08. August 2012. (2012)
Measuring the kinetics of conformational sampling during binding with NMR spectroscopy. In Protein Scinece, 344.
Meeting Abstract
78 11 Aufl., S. 1278 - 1278. International Congress on Natural Products Research on Global Change, Natural Products and Human Health/8th Joint Meeting of AFERP, ASP, GA, PSE and SIF , New York/USA, 28. Juli 2012 - 01. August 2012. (2012)
Synergistic trail sensitizers from Barleria alluaudii and Diospyros maritima. In Planta Medica, 345.
Meeting Abstract
21 (Supplement 1), S. 190 - 190. 26th Annual Symposium of the Protein-Society, San Diego; CA, 05. August 2012 - 08. August 2012. (2012)
Direct observation of correlated protein motions detected by NMR spectroscopy. In Protein Science, 346.
Meeting Abstract
21 (Supplement 1), S. 209 - 210. 26th Annual Symposium of the Protein-Society, San Diego; CA, 05. August 2012 - 08. August 2012. (2012)
N-glycan recognition by the cyanobacterial Oscillatoria aghardii lectin. In Protein Science, Sonstige (1)
347.
Sonstige
Paramagnetic lanthanide tagging for NMR conformational analyses of N-linked oligosaccharides, Chemistry-A European Journal 17, S. 9280 - 9282 (2011)
Patent (2)
348.
Patent
Mutant alpha-synuclein with increased toxicity. WO/2010/015714 (2010)
349.
Patent
New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases. WO/2010/00372 (2010)
Datenpublikation (1)
350.
Datenpublikation
High-power relaxation dispersion NMR data set at different ligand concentrations: a litmus test for classification of recognition mechanism. (2022)
Preprint (3)
351.
Preprint
The amyloid oligomer modulator anle138b has disease modifying effects in a human IAPP transgenic mouse model of type 2 diabetes mellitus (hIAPP Ob/Ob mice). bioRxiv (2024)
352.
Preprint
Lipidic folding pathway of α-Synuclein via a toxic oligomer. Research Square (2024)
353.
Preprint
[11C]MODAG 005 – a novel PET tracer targeting alpha-synuclein aggregates in the brain. Research Square (2024)